GRPR gene The gastrin-releasing peptide receptor (GRPR) is a crucial G protein-coupled receptor (GPCR) that plays a significant role in various physiological processes, including gastrointestinal function and neuronal signaling.Physiology, Gastrin - StatPearls - NCBI Bookshelf This receptor is the primary target for gastrin-releasing peptide (GRP), a neuropeptide involved in hormone release, food intake regulation, and the transmission of itch signals. Beyond its normal physiological functions, GRPR has emerged as a prominent target in oncology, as its overexpression is frequently observed in several human cancers, including prostate, breast, and small cell lung cancers. This has spurred considerable research into GRPR-targeting strategies for both diagnostic imaging and therapeutic interventions.GRPR gastrin-releasing peptide receptor
Gastrin-releasing peptide receptor, also known by its gene symbol GRPR, is a transmembrane protein belonging to the bombesin receptor family.Gastrin-releasing peptide receptor It is structurally similar to other bombesin receptors, such as neuromedin B receptor (NMBR). GRPR primarily functions by binding to gastrin-releasing peptide (GRP) and other bombesin-like peptides. Upon ligand binding, GRPR initiates intracellular signaling cascades, notably through the activation of phospholipase C, which ultimately influences cellular functions such as proliferation, survival, and differentiation.
In the gastrointestinal system, GRPR is involved in regulating the release of gastrin and other hormones, influencing digestive processes.The gastrin-releasing peptide/bombesin system revisited ... In the central nervous system, GRP acting through GRPR is implicated in appetite control and sensory perception, including the processing of itch signals.Contributes to the regulation of food intake. Contributes to the perception of prurient stimuli and transmission of itch signals in the spinal cord that promote ... The identification of GRPR's role in these diverse biological pathways highlights its multifaceted importance.
The aberrant overexpression of GRPR in various malignancies has positioned it as a highly attractive target for cancer diagnosis and treatment.GRPR This heightened expression is particularly notable in prostate cancer, where GRPR is found in a significant percentage of lymph node and bone metastases. It is also overexpressed in breast cancer, head and neck tumors, and small cell lung cancer, among othersGastrin-Releasing Peptide Receptor - an overview. This specific expression pattern in cancerous tissues, often with lower expression in healthy tissues, makes GRPR an ideal candidate for targeted therapies.
Researchers are actively developing novel strategies to leverage GRPR for cancer management. These include:
* Radiotheranostics: Combining diagnostic imaging with targeted radionuclide therapyStructures of human gastrin-releasing peptide receptors .... GRPR-targeted imaging agents can help visualize tumor sites and metastases, while therapeutic radionuclides delivered to the receptor can selectively irradiate cancer cells.作者：P Gastrin-releasing—Gastrin-releasing peptide receptor(GRPR; GRP-R). Published: 27 August 2009. Volume 2, page 1285, (2009); Cite this article. Download PDF. Save article.
* Targeted Drug Delivery: Utilizing GRPR as a delivery vehicle for cytotoxic drugs. By conjugating chemotherapeutic agents to ligands that bind to GRPR, researchers aim to deliver potent anti-cancer drugs directly to tumor cells, minimizing systemic toxicity.
* Molecular Imaging: Developing specific probes for PET or SPECT imaging to detect and monitor GRPR expression in tumors, aiding in diagnosis, staging, and treatment response assessment.
The study of GRPR is closely intertwined with research on gastrin-releasing peptides and the broader bombesin receptor family. Bombesin, originally isolated from frog skin, is a well-studied peptide that shares functional similarities with GRP.BB 2 receptor The development of selective GRPR ligands and the elucidation of its crystal structures have been significant advancements, providing deeper insights into its mechanism of action and facilitating the design of more effective therapeutic agentsA Vision for Gastrin-Releasing Peptide Receptor Targeting for .... Research into GRPR also extends to understanding its role in non-cancerous conditions, such as autism spectrum disorder and agoraphobia, as indicated by genetic associations.
The ongoing exploration of GRPR's intricate roles in both normal physiology and disease pathogenesis promises further breakthroughs in understanding and treating a range of conditions, with a particular focus on its significant potential in the fight against cancer.
Join the newsletter to receive news, updates, new products and freebies in your inbox.